Speaker

Andreas Varkaris

MD, Harvard Medical School

Andreas Varkaris, Harvard Medical School, spoke at 8th RAS-Targeted Drug Development Summit (Boston, United States of America, 8–10 Sept 2026) in the session “Is Perfect Selectivity Necessary? Rethinking KRAS Targeting in the Era of Resistance”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

8th RAS-Targeted Drug Development Summit
8–10 Sept 2026Boston, United States of America
- SpeakerIs Perfect Selectivity Necessary? Rethinking KRAS Targeting in the Era of Resistance

More speakers at 8th RAS-Targeted Drug Development Summit

Luke Pase
Chief Technology Officer, Anocca AB
Nagi Ayad
Professor, Georgetown University
Stephanie Braun
Executive Director & Head of Enzalutamide, Medical Affairs (US), Astellas Pharma
Silvia Coma
Senior Director, Translational & Preclinical Research, Verastem, inc
Peter DeMuth
Chief Scientific Officer, Elicio Therapeutics
Matthew Farren
Senior Research, Pharmacology Investigator, Incyte Corporation

See all 32 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Andreas Varkaris, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].